Previous study showed that AKR1C1/C2 were associated with EDHB-induced inhibition of esophageal cancer cell proliferation and this might promote treatment of esophageal cancer using EDHB, a substrate of the enzymes (Li et al., 2016). This evidence concerns the gene AKR1C1 and esophageal cancer.